GlassScriptPhysician profile
Andrew J Wassef
NPI 1982848099
$1,525,332.61
in general payments reported to CMS, 2019-2025
19 companies · $338K in 2025
The $338K reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148K · 2020: $133K · 2021: $129K · 2022: $170K · 2023: $324K · 2024: $284K · 2025: $338K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $550K · Royalty Or License: $272K · Travel and Lodging: $112K · Food and Beverage: $12K · Entertainment: $18.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $549,992.50 |
| Royalty Or License | $271,900.93 |
| Travel and Lodging | $111,516.00 |
| Food and Beverage | $12,177.06 |
| Entertainment | $18.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,231,032.62 | 2019-2025 | Mako, Triathlon, Insignia |
| Austin Medical Ventures INC | $251,346.18 | 2019-2025 | Synthecure, Synthecure Calcium Sulfate |
| Heraeus Medical, LLC. | $20,984.42 | 2025 | Synthecure |
| Bone Support INC. | $19,022.61 | 2019-2023 | Ceramentbone Void Filler |
| Zimmer Biomet Holdings, INC. | $1,008.33 | 2019-2025 | Comprehensive Shoulder System, Arcos, Rosa |
| Kci USA, INC. | $902.28 | 2020-2023 | Prevena Restor Arthroform, Prevena, V.A.C. Veraflo |
| Dynasplint Systems INC. | $191.67 | 2021 | |
| Next Science LLC | $171.80 | 2024 | Xperience, Blastx, Surgx |
| Horizon Therapeutics Plc | $161.91 | 2019-2021 | |
| Globus Medical, INC. | $106.75 | 2022-2023 | Ankle Fracture System |
| Overture Orthopaedics | $83.53 | 2025 | Overtureti |
| Pacira Pharmaceuticals Incorporated | $66.80 | 2019-2025 | Exparel |
| Orthofix Medical, INC. | $64.07 | 2025 | Physio-Stim |
| Smith+Nephew, INC. | $63.23 | 2022-2025 | Pico 14, Pico 7 |
| Bioventus LLC | $40.08 | 2019-2023 | Gelsyn-3 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $30.04 | 2019-2023 | Orthovisc |
| Vertex Pharmaceuticals Incorporated | $22.57 | 2025 | |
| Ermi LLC | $17.30 | 2019 | |
| Pacira Therapeutics, INC. | $16.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$45,714.24 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Wassef listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.